PCSA logo

Processa Pharmaceuticals (PCSA) Total Debt

Annual Total Debt

$150.50 K
-$79.00 K-34.42%

31 December 2023

PCSA Total Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Debt

$96.90 K
-$21.90 K-18.43%

30 September 2024

PCSA Quarterly Total Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PCSA Total Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-34.4%-43.5%
3 y3 years-54.1%-4.6%
5 y5 years-34.6%-60.3%

PCSA Total Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-54.1%+91.7%-60.9%+209.6%
5 y5 years-85.4%+91.7%-94.6%+209.6%
alltimeall time-94.0%+91.7%-96.1%

Processa Pharmaceuticals Total Debt History

DateAnnualQuarterly
Sept 2024
-
$96.90 K(-18.4%)
June 2024
-
$118.80 K(-15.4%)
Mar 2024
-
$140.40 K(-6.7%)
Dec 2023
$150.50 K(-34.4%)
$150.50 K(-12.2%)
Sept 2023
-
$171.50 K(-10.3%)
June 2023
-
$191.20 K(-9.2%)
Mar 2023
-
$210.60 K(-8.2%)
Dec 2022
$229.50 K(+192.4%)
$229.50 K(-7.5%)
Sept 2022
-
$248.00 K(+692.3%)
June 2022
-
$31.30 K(-43.3%)
Mar 2022
-
$55.20 K(-29.7%)
Dec 2021
$78.50 K(-76.1%)
$78.50 K(-22.7%)
Sept 2021
-
$101.60 K(-17.6%)
June 2021
-
$123.30 K(-59.9%)
Mar 2021
-
$307.20 K(-6.4%)
Dec 2020
$328.10 K(-68.1%)
$328.10 K(-81.7%)
Sept 2020
-
$1.79 M(+8.3%)
June 2020
-
$1.65 M(+63.8%)
Mar 2020
-
$1.01 M(-1.8%)
Dec 2019
$1.03 M(+346.9%)
$1.03 M(+321.1%)
Sept 2019
-
$244.10 K(-50.6%)
June 2019
-
$494.20 K(-3.8%)
Mar 2019
-
$513.90 K(+123.4%)
Dec 2018
$230.00 K
$230.00 K(+1.0%)
Sept 2018
-
$227.80 K(+1.7%)
June 2018
-
$224.10 K(-91.0%)
DateAnnualQuarterly
Mar 2018
-
$2.48 M(+1.5%)
Dec 2017
$2.45 M(+51.9%)
$2.45 M(>+9900.0%)
Sept 2017
-
$0.00(-100.0%)
June 2017
-
$1.69 M(+4.7%)
Mar 2017
-
$1.61 M(0.0%)
Dec 2016
$1.61 M(+18.0%)
$1.61 M(0.0%)
Sept 2016
-
$1.61 M(0.0%)
June 2016
-
$1.61 M(+16.6%)
Mar 2016
-
$1.38 M(+1.2%)
Dec 2015
$1.37 M(+139.5%)
$1.37 M(-17.4%)
Sept 2015
-
$1.65 M(-2.1%)
June 2015
-
$1.69 M(+19.8%)
Mar 2015
-
$1.41 M(+147.3%)
Dec 2014
$570.60 K(-26.5%)
$570.60 K(-77.3%)
Sept 2014
-
$2.51 M(+32.4%)
June 2014
-
$1.89 M(+15.9%)
Mar 2014
-
$1.64 M(+110.5%)
Dec 2013
$776.70 K(-31.5%)
$776.70 K(-35.1%)
Sept 2013
-
$1.20 M(-43.3%)
June 2013
-
$2.11 M(+87.3%)
Mar 2013
-
$1.13 M(-0.6%)
Dec 2012
$1.13 M(-54.7%)
$1.13 M(-0.8%)
Sept 2012
-
$1.14 M(>+9900.0%)
June 2012
-
$0.00(0.0%)
Mar 2012
-
$0.00
Dec 2011
$2.50 M
-

FAQ

  • What is Processa Pharmaceuticals annual total debt?
  • What is the all time high annual total debt for Processa Pharmaceuticals?
  • What is Processa Pharmaceuticals annual total debt year-on-year change?
  • What is Processa Pharmaceuticals quarterly total debt?
  • What is the all time high quarterly total debt for Processa Pharmaceuticals?
  • What is Processa Pharmaceuticals quarterly total debt year-on-year change?

What is Processa Pharmaceuticals annual total debt?

The current annual total debt of PCSA is $150.50 K

What is the all time high annual total debt for Processa Pharmaceuticals?

Processa Pharmaceuticals all-time high annual total debt is $2.50 M

What is Processa Pharmaceuticals annual total debt year-on-year change?

Over the past year, PCSA annual total debt has changed by -$79.00 K (-34.42%)

What is Processa Pharmaceuticals quarterly total debt?

The current quarterly total debt of PCSA is $96.90 K

What is the all time high quarterly total debt for Processa Pharmaceuticals?

Processa Pharmaceuticals all-time high quarterly total debt is $2.51 M

What is Processa Pharmaceuticals quarterly total debt year-on-year change?

Over the past year, PCSA quarterly total debt has changed by -$74.60 K (-43.50%)